Peptides DB
Research-centric peptide and protocol reference hub

Thymulin (Facteur Thymique Serique) record · updated 8h ago

Healing & recoveryMetabolic & appetiteGrade B · human evidenceResearch use only
All 5 studiesJump to the evidenceCompare
What is Thymulin (Facteur Thymique Serique) used for?

FTS | Zinc-Dependent Thymic Nonapeptide

Primarily researched for · Healing & recovery

Development stage

where Thymulin (Facteur Thymique Serique) sits between preclinical work and regulatory approval
  1. 1Current
    Preclinical
    Animal / in-vitro work
  2. 2Not reached
    Phase 1
    Safety in humans
  3. 3Not reached
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 6 registered trials. It describes the research record, not a recommendation.

Identity
NameThymulin (Facteur Thymique Serique)
Full name—
Sequence—
ClassImmune
Research levelWell Studied
Discovered byCurated master list · 2026
Pharmacology
Mechanism—
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence—
Effect profile · 0–5
Healing & recovery: Healing 3.0, Muscle 0.0, Metabolic 2.0, Neuro 1.0, Sleep 0.0, Immune 2.0, Skin 0.0Healing & recovery — 3.0 / 5Metabolic & appetite — 2.0 / 5Neuro & mood — 1.0 / 5Inflammation & immune — 2.0 / 5HealingMuscleMetabolicNeuroSleepImmuneSkin3.00.02.01.00.02.00.0
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o mini over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Jul 27, 2026. How this works →
Research stats
Total studies5
Human / animal / cellular4 / 1 / 0
Highest trial phasePreclinical
Years covered1990–2026
Latest study12d ago
Publication history
19902026
Research funding
—no NIH grants found
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

5 rowsOpen in the library →
StudyTypeYearSummary depth
Antibodies to thymic hormone and HLA-DQ in type I diabetes.
FindingNot reported in abstract.
Human1990Full text read0.70
Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells.
FindingThymulin plasma concentrations in acromegaly patients: 4.24 +/- 0.97 vs. 2.67 +/- 0.87 in controls, P < 0.001.
Human1992Full text read0.80
A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection From Myocardial Infarction.
FindingNot reported in abstract.
Animal2020Full text read0.70
Causal effect between systemic inflammatory cytokines and osteoporotic pathological fractures: A bidirectional Mendelian randomization study.
FindingOR = 0.7954 for Artemin levels negatively correlated with fracture risk, P = .0167.
Human2025Full text read0.80
Clinical Significance of B7-H4 in Peripheral Blood of Patients With Myasthenia Gravis.
FindingmB7-H4 expression on CD4+ T cells significantly increased in relapsing-MG patients compared to healthy controls (p < 0.05).
Human2026Full text read0.80

Articles mentioning Thymulin (Facteur Thymique Serique)